Efficient, Effective Quality Window Washing all in a timely manner!
Location: India
Total raised: $24M
Investors 2
| Date | Name | Website |
| - | Romulus Ca... | romuluscap... |
| - | Perceptive... | perceptive... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 23.08.2016 | Series C | $14M | Perceptive... |
| 02.06.2016 | - | $2M | Romulus Ca... |
| 13.08.2014 | Series B | $8M | - |
Mentions in press and media 9
| Date | Title | Description |
| 04.01.2019 | Iron Pillar leads $22m Series D funding in India’s Vyome Therapeutics | Premium Specialty pharmaceutical company Vyome Therapeutics Inc. on Thursday announced that it has raised $22 million in a Series D round of funding led by venture capital firm Iron Pillar. Continue reading this story with a subscription to... |
| 23.08.2016 | Perceptive Advisors Leads $14M Series C for Vyome Biosciences | Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, announced today that it has closed a $14 million Series C financing round. This fina... |
| 23.08.2016 | Romulus Capital Leads $14M Series C for Vyome Biosciences | Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, announced today that it has closed a $14 million Series C financing round. This fina... |
| 22.08.2016 | Vyome Biosciences Raises $14M in Series C Financing | Vyome Biosciences, a New Delhi, India-based clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, raised $14m in Series C financing. The round was led by Perce... |
| 22.08.2016 | Vyome Biosciences gets $14 mn from Perceptive Advisors, others | Delhi-based biopharmaceutical firm Vyome Biosciences Pvt. Ltd said on Monday it has received $14 million (Rs 94 crore) in a Series C funding round led by New York-based life sciences fund Perceptive Advisors and Boston-based venture capital... |
| 02.06.2016 | VC Dealbook: Romulus invests $2m in Vyome Bio; Quadria launches $10m fund | Premium US-based venture capital firm Romulus Capital has forayed into the Indian market with a $2 million investment in Vyome Biosciences. Also, VC firm Quadria has launched a new $10 million fund focussed on healthcare startups called Hea... |
| 13.08.2014 | Vyome Biosciences Raises $8M in Series B Funding | Vyome Biosciences, a Delhi, India-based dermatology company, raised $8m in Series B funding. The round was led by Sabre Partners with participation from existing investors Kalaari Capital and Aarin Capital. The company intends to use the fu... |
| 11.08.2014 | Sabre Partners leads $8M Series B investment in Vyome Biosciences | Vyome Biosciences Pvt Ltd, which is a biopharmaceutical company focused on developing dermatology products, has closed a Series B financing round worth $8 million (Rs 48 crore) led by Sabre Partners, with participation of existing investors... |
| 12.09.2012 | Vyome Biosciences raises $3.3M in Series A round led by IndoUS Venture Partners | Vyome Biosciences Pvt Ltd, a biopharmaceutical company with focus on dermatology and skin care products, has closed its Series A financing round of Rs 18.50 crore ($3.3 million) led by IndoUS Venture Partners (IUVP) while Aarin Capital and ... |